Objective. We assessed the orofacial involvement in JDM, and evaluated the possible association of gingival and mandibular mobility alterations with demographic data, periodontal indices, clinical features, muscle enzyme levels, JDM scores and treatment.
Introduction JDM is a rare, multisystemic disease that is characterized by vasculitis and affects a variety of tissues such as skeletal muscle, skin, gastrointestinal tract, lungs, kidneys, eyes, heart [1] [2] [3] and testicles [4] .
The masticatory system can also be affected in idiopathic inflammatory myopathies (IIM), but only few studies have focused on orofacial involvement in these diseases, including one in adults [5] and three case reports in children and adults [6] [7] [8] . However, no evidence of gingival systemic involvement was observed, whereas worse dental condition and oral hygiene were reported in adults with IIM that was mainly associated with hyposalivation, with normal mandibular mobility [5] . On the other hand, the few cases of oral mucous evaluation in patients with JDM described a peculiar gingival bushy loop formation [8] and telangiectasia [6] . All six patients had active disease, but the study design precluded a more extensive definition of the possible association with clinical and laboratory parameters. In addition, no data are provided about the evaluation of mandibular mobility in JDM.
Therefore, the aims of this study were to assess the global orofacial involvement in patients with JDM compared with controls, and to evaluate the possible association of gingival and mandibular mobility alterations with demographic data, periodontal indices, clinical features, muscle enzyme levels, JDM scores and treatment.
Patients and methods
We studied 26 patients with JDM who were regularly followed up at the Paediatric Rheumatology Unit of our university hospital. All patients fulfilled the Bohan and Peter criteria for the diagnosis of PM and DM [9] . The control group included 22 healthy children and adolescents who visited the Paediatric Dentistry Unit of the same hospital for the first time. Exclusion criteria were orthodontic appliances, cognitive alterations, smoking habit and alcohol use. The local ethical committee (Comissã o de É tica e Pesquisa do Hospital das Clínicas da Faculdade de Medicina da Universidade de Sã o Paulo) approved this study and written informed consent was obtained from participants or their legal guardians.
This study included an evaluation of demographic data (age at onset of JDM, current age, disease duration and sex), global orofacial evaluation, clinical features of JDM, JDM scores, muscle enzyme levels and treatment profiles. Brazilian socio-economic class was defined as previously reported [10] , with Class C as the middle socio-economic class.
Global orofacial assessment was done by one calibrated dentist at study entry, who was blinded to the clinical features of JDM, JDM scores, muscle enzyme levels and treatment profile. The global orofacial assessment included five parameters: orofacial clinical features, dental condition, periodontal assessment, mandibular function and salivary flow rate.
The Equipe de Dor Orofacial -Hospital das Clínicas (EDOF-HC) protocol is a standardized orofacial pain and clinical questionnaire that evaluates the main complaint, general characteristics of pain and features of teeth, periodontium, and oral mucosal and temporomandibular abnormalities [11] . The dental condition was determined according to the international standardized epidemiological index or decayed, missing and filled teeth (DMF-T) index that considers the number of decayed, missing and filled primary and permanent teeth [12] .
The periodontal evaluation was done by three standardized epidemiological indices: dental plaque index (PI) [13] , gingival bleeding index (GBI) [14] and clinical dental attachment. Clinical dental attachment included three other parameters: probing pocket depth (PPD), cementoenamel junction (CEJ) and clinical attachment level (CAL), at six sites per tooth [15] .
PI was used to evaluate the level of oral hygiene, which was calculated according to the number of dental surfaces stained by a dental plaque disclosing agent, multiplied by 100 and divided by the total number of surfaces [13] . GBI was used to evaluate gingival inflammation, and was expressed as the number of bleeding surfaces after probing with a periodontal probe, which was then multiplied by 100 and divided by the total number of surfaces [14] . PPD was determined as the distance from the bottom of the pocket to the gingival margin. CEJ was measured as the distance from the gingival margin to the CEJ, identifying hyperplasia or recession. CAL was calculated as the sum of PPD and CEJ [15] .
Signs and symptoms of temporomandibular disorders (TMDs) were recorded using the Helkimo's index [16] , which was determined by the clinical dysfunction index (CDI) and the mandibular mobility index (MMI). CDI was used to evaluate five dysfunction clinical signs: jaw mobility, impaired temporomandibular joint (TMJ) function, jaw muscle pain, TMJ pain and pain on mandibular movements. MMI was used to evaluate the mandibular movements: maximum interincisal opening, right and left movements and protrusion. In addition, the Research Diagnostic Criteria for TMDs (RDC/TMD) Axis I [17] , which establish the diagnostic criteria for TMDs, were also evaluated.
We assessed the unstimulated and stimulated whole-saliva flow rate. Samples were collected in the same hour, always in the same room under similar room temperatures. Collection time for each sample was 2 min. The saliva was collected from the floor of the mouth using two pieces of rolled cotton previously weighed within a tube in an analytical balance [18] . The volume of saliva was determined by weighing the tube with the rolled cotton before and after the collection. The stimulation of salivary flow was done using two drops of 2% citric acid and flow rates were expressed in millilitres per minute.
JDM clinical manifestations were assessed concomitantly to global orofacial assessment and included cutaneous lesions (heliotrope rash, Gottron's papules, vasculitis, calcinosis, ulcerative skin lesions or malar rash), articular involvement (arthralgia or arthritis), muscular involvement (muscle weakness according to the Medical Research Council criteria and muscle oedema), cardiopulmonary disease according to abnormalities on pulmonary function test or pulmonary multislice CT, or Doppler echocardiogram or all three (serositis, myocarditis, restrictive lung disease and pulmonary hypertension) and gastrointestinal involvement according to X-rays of the oesophagus, stomach and duodenum abnormalities or abdominal ultrasound (dysphagia or vasculitis).
JDM disease scores were assessed concomitantly to global orofacial assessment (same day) using various tools such as physician's global assessment (PGA) of disease activity, DAS [19, 20] , Myositis Disease Activity Assessment Analogue Scales (MYOACTs) [21] , Myositis Intention to Treat Activity Index (MITAX) [21] , Childhood Myositis Assessment Scale (CMAS) [22] and Kendall Manual Muscle Testing (MMT; 0-10 scale), which tested eight muscle groups [23] .
The serum muscle enzymes collected concomitantly to global orofacial assessment were creatine kinase (CK), alanine aminotransferase (ALT), aspartate aminotransferase (AST), aldolase and lactate dehydrogenase (LDH).
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Statistical analysis
The Kolmogorov-Smirnov test was used to evaluate the distribution of all data. Results are presented as the median (interquartile range) or mean (S.D.) for continuous variables with asymmetric and normal distribution, respectively, and as number (%) for categorical variables. For continuous variables, data were compared with t-tests to evaluate differences between current age of patients with JDM and controls, and with the Mann-Whitney U-test to evaluate differences between patients with JDM and controls, and JDM subgroups according to the gingival and mandibular mobility alterations. For categorical variables, differences were assessed using Fisher's exact test. P < 0.05 was considered statistically significant. Bonferroni correction was used for multiple comparisons to adjust the significant level to P < 0.0125 and included four variables: gingival vasculopathy pattern, reduced opening of the mouth, skin DAS and MMT.
Results

Evaluation of patients with JDM and controls
Demographic data. The mean current age and frequency of female and socio-economic Class C were similar for patients with JDM and controls [11.8 (3. 97) (5.5-18.5) vs 11.6 (2.85) (7.3-16.4) years, P = 0.469; 58 vs 45%, P = 0.563; 73 vs 86%, P = 0.307, respectively; Table 1 ].
Orofacial clinical features and dental condition. A unique gingival pattern (gingival vasculopathy pattern) characterized by capillary dilation, gingival erythema and bush-loop formation ( Fig. 1 ) that extends over the upper or lower teeth, or both, was only clinically observed in patients with JDM but not in controls (61 vs 0%, P = 0.0001). This association remained significant after Bonferroni correction for multiple testing. Similarly, telangiectasias (small, dilated blood vessels near the surface) of the oral mucosal (Fig. 2) were also observed only in patients with JDM (23 vs 0%, P = 0.023), and five (83%) of the six patients concomitantly had an unusual gingival pattern. These telangiectasias were located on the mucosa of the bucca and the lower lip. A trend for a high frequency of orofacial complaints, mainly toothache in four patients, was observed in the patients than in the controls (19 vs 0%, P = 0.053). No significant differences were found between the frequencies of other orofacial features in JDM and controls, according to the EDOF-HC protocol. The evaluation of dental condition revealed that the median for DMF-T index was comparable in both the groups [2 (0-12) vs 1.5 (0-9), P = 0.151; Table 1 ].
Periodontal assessment. The median values for PI, GBI, PPD and CEJ were alike in both groups (89.4 vs 80.9%, P = 0.323; 21.7 vs 12.7%, P = 0.141; 1.83 vs 1.56 mm, P = 0.198; À0.12 vs À0.10 mm, P = 0.708, respectively). A trend for higher CAL was observed in patients with JDM than in the controls (1.25 vs 1.04 mm, P = 0.078), although within the normal range (Table 1) .
Mandibular function. The analysis of Helkimo's index revealed that the frequency of mandibular mobility alteration was significantly higher in the patient group (50 vs 14%, P = 0.013). Similarly, the patients showed significantly higher frequencies of reduced mouth opening (31 vs 0%, P = 0.005; Table 1 ). This association remained significant after Bonferroni correction for multiple testing.
The median for mouth opening was lower in patients with JDM than in controls [42 (19-60) vs 45 (40-51) mm, P = 0.01], whereas no differences were observed in left and right mandibular movement and protrusion [9 (4-12) vs 9 (7-13), P = 0.089; 8 (4-12) vs 9 (5-12), P = 0.324; 8 (4-11) vs 8 (4-12), P = 0.812, respectively]. The frequencies for mandibular CDI were similar between the patient and control groups (69 vs 59%, P = 0.551).
According to the RDC/TMD, 35% of patients with JDM fulfilled myofascial pain diagnostic criteria compared with 50% of controls (P = 0.381). Arthralgia was similar in both groups (31 vs 23%, P = 0.745; Table 1 Demographic data. The medians for current age [11.2 (5.9-18.5) vs 13 (5.5-17.9) years, P = 0.544], age at onset [5.6 (2.5-11.5) vs 6 (3-10) years, P = 0.785] and disease duration [4.6 (1.8-11.5) vs 5.9 (0.5-11.1) years, P = 0.585] were similar in both groups. Similarly, the percentages of females and socio-economic Class C were alike in both groups (56 vs 60%, P = 1.0; 81 vs 60%, P = 0.369; Table 2 ).
Periodontal assessment. The median for GBI of JDM patients was higher in those with gingival vasculopathy pattern (27.7 vs 14%, P = 0.046) and lower values of median for CEJ than patients without this pattern (À0.26 vs À0.06 mm, P = 0.013). The Pl, PPD and CAL were not statistically significant between both groups (100 vs 77.8%, P = 0.332; 1.91 vs 1.74 mm, P = 0.292; 1.23 vs 1.25 mm, P = 0.482, respectively).
JDM scores and clinical features. The analysis of cutaneous disease activity according to the DAS score for skin showed that the median for this score was significantly higher in patients with gingival vasculopathy pattern than those without this alteration [2.5 (0-9) vs 0.5 (0-2), P = 0.029]. This association did not remain significant after Bonferroni correction for multiple testing. No differences were observed in the medians for PGA, total DAS, MYOACT cutaneous (MYOACT-C), MYOACT skeletal (MYOACT-S), MITAX, CMAS and MMT scores. The frequencies of clinical features were also alike in both the groups (Table 2) . Table 2) .
Treatment profile. No differences were observed in current use, current and cumulative doses of prednisone. The 19% frequency of the gingival abnormalities in patients using ciclosporin vs those who were not taking this drug did not reach statistical significance (P = 0.261; Table 2 ).
The median for the current dose of MTX was significantly higher in the patients with gingival vasculopathy pattern [28.7 (17.7- The medians for PGA, MYOACT-C, MYOACT-S and CMAS were similar for the two groups. No differences were observed in the frequencies of clinical findings in both groups (Table 3) . .244] were similar in JDM patients with reduced mouth opening than normal mouth opening. Similarly, the frequencies of elevated muscle enzyme levels were alike in both the groups (Table 3) .
Treatment profiles. No differences were observed in current use, current and cumulative doses of prednisone and MTX. The frequency of current use of ciclosporin was significantly higher in patients who had reduced ability to open the mouth than the controls (37 vs 0%, P = 0.023; Table 3 ). The frequency of current use of chloroquine diphosphate was alike in both groups (37 vs 28%, P = 0.667).
Discussion
To our knowledge, this is the first systematic global orofacial evaluation of patients with JDM, which extends previous observation of unique gingival abnormality and reduced mandibular mobility in JDM. The advantage of our study design was the systematic periodontal evaluation using an established criteria and the inclusion of a healthy control group. Gingivitis and periodontitis are very common in the general population [24] and the definition of a unique pattern requires the exclusion of this condition. In addition, the selection of non-smokers is relevant because smoking is known to be a significant risk indicator for worse oral health outcomes [25] . Moreover, the comparison of socio-economic class and age allowed for a precise evaluation, as these factors directly affect the buccal status [24, 26, 27] . The DMF-T values observed in patients with JDM and controls were higher than that recommended by the World Health Organization in 2010 [28] , but was comparable in both the groups. Additionally, our patient group had normal saliva flow rates compared with adults with Mandibular Mobility Index (MMI) in whom hyposalivation was the main cause for oral infections [5] .
The gingival pattern observed in JDM patients confirms and extends previous observations (a unique pattern characterized by gingival erythema, capillary dilation and bush-loop formation [6, 8] ), but were not present in healthy controls. One limitation of this study was that the assessors were not blinded to gingival abnormalities. Moreover, changes to the gingival capillary could be part of the vasculopathy associated with JDM, as this pattern was not observed in our population with JIA [29] and juvenile SLE (JSLE) [30] . Notably, the overall gingival abnormalities were probably not associated with treatment of ciclosporin, but we cannot exclude that this drug may have contributed exclusively to the gingival enlargement-a known complication of this therapy [31] . Oral telangiectasia was also reported in adults with IMM [5] , mainly on the mucosa of the lower lip, as also observed in our study.
The unique gingival pattern in patients with JDM was not linked to poor oral hygiene or dental attachment loss in spite of hyperplasia and gingival bleeding. This finding excludes local gingival disease [32] , such as gingivitis and periodontitis, as the direct cause of these gingival alterations leading to the hypothesis of a disease-triggering effect reinforced by the association with cutaneous disease activity and higher current dose of MTX. Adverse effects of this drug in the oral cavity, such as oral ulcers and infections (e.g. oral candidiasis) were not clinically observed in our patients [33, 34] . Oral candidiasis has distinct features from the pattern described here, with a www.rheumatology.oxfordjournals.org characteristic white lesion that can be wiped off the mucosa with gauze [35] .
The possible association of this vessel pattern with periungual capillary changes in JDM has been reported [6, 8] and deserves further investigation because nail-fold capillaroscopy changes seem to be associated with persistent involvement of the skin [36] . The lack of association with muscular activity confirms previous observation of dissimilar pathophysiological mechanisms in skin compared with muscles [36] .
Another aspect observed in our study was the reduction of mandibular mobility, specifically the ability to open the mouth in patients with active JDM, reinforcing the possibility that this finding is an additional manifestation of JDM in the masticatory system and a consequence of muscle weakness. Mandibular mobility alteration was also observed in our patients with JIA due to TMJ involvement [29] and in JSLE patients [30] .
In conclusion, the gingival vasculopathy pattern associated with hyperplasia and gingival bleeding, distinct from periodontal disease and associated with cutaneous disease activity, suggests that gingiva is a possible target tissue for JDM. In addition, muscle weakness may be a relevant factor for reduced mandibular movement in active disease.
Rheumatology key messages
. Gingiva is a possible target tissue for JDM associated with cutaneous disease activity. . Muscle weakness may contribute to reduced mandibular movement in JDM.
